Skip to main content
Download PDF

Factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia: a cross-sectional study

BMC Cancer volume 22, Article number: 1309 (2022) Cite this article

Abstract

Background

In many middle-income countries, cancer incidence and mortality are rapidly increasing, but data for developing a strategy of cancer control are rarely collected or analyzed. This study aimed to identify factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia.

Methods

The data of 79,660 women who had visual inspection with acetic acid (VIA) and 83,043 women who had clinical breast examination (CBE) in the Jakarta Women Cancer Screening program in 2019 were included in this study. Socio-demographic factors, reproductive factors, lifestyle factors, family history, and the results of VIA and CBE were used for analyses. Binary and multivariate logistic regression analyses were performed to identify factors associated with VIA positive or CBE positive.

Results

The positive rate was 0.9% for both VIA and CBE among the screening participants. Factors associated with VIA positive were age < 30 years old, age at menarche ≤ 11 years old, remarriage, lower educational level, having an occupation, partner’s occupation other than being an employee, alcohol consumption, smoker, inadequate physical activity, cancer family history, and no Pap smear history. Factors associated with CBE positive were age at menarche ≤ 11 years old, widowed, high education, having an occupation, no breastfeeding history, birth control history, alcohol consumption, smoker, inadequate physical activity, cancer family history, and breast tumor history.

Conclusion

Factors associated with VIA positive and CBE positive among Indonesian women were revealed. To promote female cancer prevention in Indonesia, the prevalence of screenings should be increased and education about the risk factors should be provided to medical professionals.

Peer Review reports

Introduction

Cancer was the second leading cause of death in the world in 2018, but most cancer deaths occur in low- and middle-income countries [1]. Cancer incidence and cancer mortality are rising rapidly in middle-income countries, and the proportion of advanced cancers and the case fatality rate are higher compared to high-income countries [1,2,3,4]. Prevention and early detection are the major strategies for cancer control, but the data for these strategies, such as the incidence, risk factors, outcomes, and stages at diagnosis, are not revealed in most middle-income countries.

In low- and middle-income countries, cervical cancer is the leading cause of female cancer death and the incidence of cervical cancer was the highest besides breast cancer in several countries [1, 5]. Papanicolaou (Pap) smear is the most common screening method for cervical cancer worldwide and human papillomavirus (HPV) vaccination is the most effective preventive method [6, 7]. However, visual inspection using acetic acid (VIA) is used in places with limited resources [8], where a Pap smear or an HPV test are not available. A meta-analysis including 29 studies reported that the sensitivity and specificity of VIA for cervical intraepithelial neoplasia (CIN) grade 2 or worse were 73.2% and 86.7%, respectively [9]. For screening breast cancer, clinical breast examination (CBE) is used instead of mammography in developing countries [10]. CBE contributes to down-staging of 17–47% of breast cancers from the advanced stage to the early stage [11]. Previous studies reported that the sensitivity and specificity of CBE is 50–54% and 94–98%, respectively [12,13,14]. VIA and CBE are non-invasive and cheap methods and the results of VIA and CBE can be available immediately after examinations [15, 16]. Therefore, VIA and CBE are alternative screening methods in low- and middle-income countries. In Asia, VIA is used in the cervical cancer screening program in Bangladesh [17], Thailand [18], India [19], and China [20] and CBE is the first choice for breast cancer screening in low- and middle-income countries [10, 21].

In Indonesia, a middle-income country in Southeast Asia, the most common cancer in women is breast cancer followed by cervical cancer [1, 22]. A screening program using VIA and CBE was introduced in 2007 and developed into a national program in 2015 to provide cancer screening services widely and increase cancer awareness [15, 23]. There are some studies on VIA or CBE that included women at hospitals or civil servants in Indonesia [23,24,25,26]. The studies reported that the VIA positive rate was 1.4–4.7% and that the risk factors for positive VIA were the number of marriages, parity, smoking, and less use of hormonal contraception [23, 24]. Wahidin et al. reported the coverage, the positive rate, and the suspected cancer prevalence in cervical and breast cancer screening program in Indonesia [27]. However, to date there has been no population-based study on risk factors of female cancers in Indonesia. This study aimed to identify the factors associated with positive cancer screening for the uterine cervix and breast using the data of the national screening program in Jakarta Province in 2019.

Methods

Study design and participants

This study is a cross-sectional study and used the secondary data of all female citizens of Jakarta who had VIA and/or CBE in 2019, which were taken from the Jakarta Women Cancer Screening Database in Jakarta Department of Health. Women who reached menarche, had sexual intercourse, were not pregnant, had an intact uterus, and had no history of CIN or cervical cancer were eligible for VIA. Women who had menarche, were not pregnant, and were not receiving treatment for breast cancer could have CBE. Women had VIA and CBE when they had no menstrual bleeding. Written informed consent for VIA, CBE, and cryotherapy was obtained after a complete explanation in conjunction with asking several questions related to their conditions by a doctor using “the women cancer early detection procedure form” (Additional file 1). Women had VIA and/or CBE at 334 public health centers or in specific places, such as village schools or community centers, by mobile screening teams on mutually suitable dates. Three clinics that were supported by the University of Indonesia and the Indonesian Cancer Foundation also provided screenings to women. In 2019, the total female population was 5,272,489 in the province and the number of target women (30–50 years old) was estimated as 1,665,148. In fact, 79,660 women had VIA, 83,043 women had CBE, and 78,934 women underwent both VIA and CBE. The coverage of VIA and CBE was estimated to be 5.0% and 4.8%, respectively. The medical records of 9,566 women who had VIA and 12,222 women who had CBE had missing data regarding the 15 variables that were used in the statistical analyses and the women were excluded in this study. Finally, we included 70,094 women who had VIA and 70,821 women who had CBE in the study (Fig. 1).

Fig. 1
figure 1

Flow diagram of participants of this study. This study included 70,094 of 79,660 women who had VIA and 70,821 of 83,043 women who had CBE. VIA, visual inspection with acetic acid; CBE, clinical breast examination

Full size image

VIA

A doctor with two midwives or nurses formed a team and conducted VIA. After applying 3–5% acetic acid to the cervix for a minute, the cervix was observed. The result was positive when an acetowhite area was found in the transformation zone, negative when no change was observed, and suspicion of invasive cancer when a growth or ulcerative lesion was found. When a woman had a positive result, doctors provided cryotherapy after obtaining written informed consent from her husband. When the result was suspicion of invasive cancer, the woman was referred to a hospital. The maximum number of VIA tests per day by a team was 35 to ensure the quality of tests.

CBE

CBE was performed by female doctors or nurses who underwent CBE training to recognize different types of abnormalities and warning signs in the breasts [28]. The training was provided by the Ministry of Health or the Jakarta Department of Health. When an abnormal breast mass was detected or palpable, the woman was referred to a hospital for mammography or ultrasonography.

Data collection

The data of all women who underwent VIA and/or CBE were sent from public health centers and the three clinics to the Jakarta Department of Health and saved in the Jakarta Women Cancer Screening Database. For this study, the results of VIA and CBE and the following 15 variables were derived from the database: age, age at menarche, marital status, partner’s marital status, educational level, occupation, partner’s occupation, alcohol consumption, smoking habit, daily physical activity, history of breastfeeding, birth control history, Pap smear history, breast tumor history, and the family history of cancer. Age was divided into four groups with 10 years intervals. Based on a previous study that showed that most Indonesian girls reached menarche at 12–14 years old [29], the age of menarche was divided into three groups: 9–11 years, 12–14 years, and 15–17 years. Marital status was categorized into three groups: single/first marriage, remarriage, and widowed. The educational level was divided into three groups: low (none and elementary school), middle (junior high school and high school), and high (bachelor and master degrees). Occupation was categorized into two groups (housewife and other), because most respondents were housewives. Partner’s occupation was also divided into two groups (employee and other) and others included traders, army, manual labor, and others. Alcohol consumption was defined as having one drink or more per day. Regarding smoking, smokers and passive smokers were classified into “yes.” The daily physical activity was set at 30 min per day based on the World Health Organization recommendation that adults should perform at least 150–300 min of moderate-intensity aerobic physical activity throughout a week for substantial health benefits [30]. Birth control history was defined as having an experience of using contraception methods, such as an intrauterine device, condom, pill, shot, and implant.

Statistical analysis

Data were analyzed using Statistical Package for Social Sciences, version 27 (IBM SPSS Inc, Armonk, NY, USA). Logistic regression analyses were performed to obtain odds ratio (OR) and 95% confidence interval (CI). In multivariable analyses on VIA positive and CBE positive, the forced-entry method was used including all the 15 variables. Statistical significance was set at P < 0.05. The Hosmer-Lemeshow test was performed to assess the fit of the logistic regression model and the results indicated a good fit of the model for the data to identify factors associated with VIA positive (P = 0.776) and CBE positive (P = 0.354).

Ethical considerations

This study was approved by the Ethics Committee of Nagoya University Graduate School of Medicine (approval number 2021 − 0130). Written informed consent was taken from each woman who had VIA and/or CBE in the program. All methods were performed in accordance with the relevant guidelines and regulations.

Results

Number of tests and results in the women cancer screening program in Jakarta, 2019

In 2019, 79,660 and 83,043 women underwent VIA tests and CBEs, respectively (Table 1). The number of target women of the program in Jakarta Province was 1,665,148. Of 79,660 women, 756 women (0.9%) were positive for VIA, including 74 women who were strongly suspected of having invasive cervical cancer. On the other hand, 753 women (0.9%) of 83,043 women showed positive CBE findings. Women who underwent cryotherapy accounted for only 24.9% (n = 188) of women who were positive for VIA. Most women (99.3%) underwent tests at public health centers or in their communities. East Jakarta had the highest number of screening tests. Women who underwent screenings at the clinics had the highest positive rate of both VIA (8.1%) and CBE (5.2%).

Table 1 Number of tests and results in the women cancer screening program
Full size table

Characteristics of women who had VIA and CBE

The data of 70,094 VIA and 70,821 CBEs were analyzed in this study. Most women were aged 40–49 years (VIA, 35.3%; CBE, 35.2%), reached menarche at 12–14 years old (VIA, 83.6%; CBE 83.6%), and were single or married for the first time (VIA, 93.3%; CBE, 93.3%) (Table 2). The main educational level was the middle level (VIA, 65.4%; CBE, 65.2%), followed by the high level (VIA, 24.6%; CBE, 24.8%). Most women were housewives (VIA, 76.0%; CBE, 75.9%). Regarding lifestyle factors, most women did not consume more than one alcoholic drink per day (VIA and CBE, 99,1%) and were not smokers (VIA, 90.5%; CBE, 90.4%). Only 25.3% (both VIA and CBE) had daily physical activity totaling more than 30 min. Most respondents had a history of breastfeeding (VIA, 67.7%; CBE, 67.6%) and had used birth control methods in their lives (VIA, 62.0%; CBE 61.7%). Only 11.2% of women had a Pap smear in both of the groups of VIA and CBE. Women with a history of breast tumors and cancer in family members were 1.1% and 1.2%, respectively.

Table 2 Characteristics of women who took VIA and CBE in the screening program
Full size table

Factors associated with VIA positive

Of the 70,094 women, 727 (1.0%) were positive for VIA. Binary and multivariate logistic regression analyses were performed on positive VIA (Table 3). In binary logistic regression analysis, women who were 30–39 years old and ≥50 years old (than < 30 years old), and had a birth control history had significantly less VIA positive (Table 3). Reaching menarche at 9–11 years old (rather than 15–17 years), remarriage (rather than single/first marriage), low and middle educational level (rather than high educational level), alcohol consumption, smoker, inadequate daily physical activity, no history of breastfeeding, and cancer family history were associated with positive VIA. Multivariate analyses adjusted by all variables in Table 3 showed that factors associated with positive VIA were menarche at 9–11 years old (compared to 15–17 years), remarriage (compared to single/first marriage), a low educational level (compared to a high level), having a job, husband’s job other than employee, alcohol consumption, smoker, inadequate physical activity, no Pap smear history, and a cancer family history. Women in the age groups of 30–39 years and ≥ 50 years were significantly less likely to be VIA positive than those in the age group < 30 years.

Table 3 Odds ratio and 95% confidence interval of VIA positive among 70,094 women
Full size table

Factors associated with CBE positive

Of the 70,821 women, 574 women (0.8%) were positive for CBE. Binary logistic regression analysis showed that menarche at 9–11 years old (rather than 15–17 years old), widowed (rather than single/first marriage), occupation other than a housewife, alcohol consumption, smoker, inadequate daily physical activity, birth control history, breast tumor history, and cancer family history were associated with positive CBE (Table 4). Women who had a low or middle educational level (rather than the high level) were significantly less likely to have CBE positive. In multivariate analysis, reaching menarche at 9–11 years old (rather than 15–17 years old), widowed (rather than single/first marriage), occupation other than housewife, alcohol consumption, smoker, inadequate daily physical activity, no history of breastfeeding, birth control history, history of breast tumor, and family history of cancer were associated with CBE positive (Table 4). The low or middle educational level (rather than high level) was associated with less CBE positive.

Table 4 Odds ratio and 95% confidence interval of CBE positive among 70,821 women
Full size table

Discussion

This study showed that both the VIA positive rate and the CBE positive rate were 0.9% in the Jakarta Women Cancer Screening Program in 2019. The positive rate in this study was lower than the average rate of VIA positive (3.4%) and CBE positive (5.4%) in the whole country from 2007 to 2018 but the positive rate varied among provinces (VIA, 0.6–8.9%; CBE, 0–17.2%) [27]. The positive rate can be different depending on the characteristics of women who had screening. There have been two previous studies on the VIA positive rate in Jakarta. One study included patients of the university hospital in Jakarta from 2007 to 2011 and the positive rate was 4.7% [23]. Another study used the data of cancer screening for female civil servants and wives of civil servants in Jakarta, October 2017 and the positive rate was 1.4% [26]. This study showed that the positive rate in the population-based screening was lower compared to that in the hospital-based or working place-based screening. Compared to a population-based screening, more detail information of clinical data and outcome can be collected but a positive rate can be higher in a hospital-based screening because a hospital has better medical resources and patients have some symptoms. In order to make a policy for the general population in a region or a country, results of population-based screening are more important and needed.

The CBE positive rate in Jakarta women was lower in this study than that in 2007–2008, which was 14.2% among 1,179 women [25]. The reason for the lower CBE positive rate in this study may be because this study included more women < 40 years old (46.0%) than the previous study (18.4%). In the previous study, 14 women (1.2%) of the 1,179 women were finally diagnosed as having breast cancer by ultrasound and tissue sampling [25]. Of the 14 women diagnosed as having breast cancer, all were mammography positive and 13 were CBE positive (CBE was performed by trained nurses and midwives). Of the women who were CBE positive, 41.3% were mammography positive and 7.8% were diagnosed as having breast cancer [25]. These results suggest that CBE by trained nurses and midwives is useful for the screening for breast cancer. However, a further study on the final diagnosis of breast cancer among women with CBE positive in the population-based screening program is needed to evaluate the effectiveness of CBE in the program.

This study showed socio-demographic and reproductive risk factors of cervical cancer and breast cancer in Indonesia, other than lifestyle risk factors and family cancer history. Alcohol consumption, smoker, and inadequate physical activity have already been reported as risk factors of many cancers and healthy lifestyle is recommended in cancer prevention strategies [7, 31]. Women who had menarche at a young age (9–11 years) and birth control history were associated with positive CBE. The hormonal risk factors for breast cancer are caused by the biological mechanisms and have a synergistic effect with higher education, less exercise, higher body mass index (BMI), and alcohol consumption [32, 33]. However, the socio-demographic characteristics of a population are different according to the economic status of countries. To prevent breast cancer, therefore, it is important to identify the risk factors in each country, especially low- and middle-income countries [34]. Furthermore, in middle-income countries, patient navigation services in cancer care are not well established at most health facilities, which are needed to reduce advanced cancers, poor access to affordable and high-quality treatment, and preventable cancer deaths [35, 36]. The data related to risk factors of cancers are needed for education to healthcare providers in communities in order to reduce early delays in diagnosis as well as to support patients through their treatment [37].

Factors associated with cervical cancer screening positive are different among Asian countries; older age, lower educational level, lower socioeconomic status, higher parity in Bangladesh [17]; coitarche, years of sexual activity, low BMI, multiple partner in Thailand [38]; older age (> 40 years old), post-menopause, and smoking in rural China [39]; and younger age (< 30 years old), early marriage (18–<21 years old), and early birth age in India [40]. A systematic study including 90 papers reported that factors associated with breast cancers in Asia are age, early menarche, late menopause, nulliparity, positive family history, excessive fat consumption, alcohol, and smoking [41]. These results in previous studies are almost consistent with the results in our study except for age. It is reported that the peak of annual incidence of CIN I is 20–24 years old and CIN II/III is 25–29 years old [42] and that CIN of younger patients is more regressed compared to that of older patients [43]. Therefore, younger age may be associated with cervical cancer screening positive when the screening method is VIA.

In this study, 11.2% of women had had a Pap smear and they had a lower VIA positive rate than the others. This result may suggest that women with a Pap smear history have already had treatment for CIN or cervicitis. In the female cancer screening program in Indonesia, cryotherapy is provided to women when they are found to be positive for VIA, although their husband’s consent is needed. One of benefits of VIA is providing the result and cryotherapy at the same time and place as the VIA is performed. When more women have VIA in the screening program, the VIA positive rate may decrease by providing more treatment for VIA positive women. On the other hand, there were 1.2% of women who had breast tumor history, which was associated with CBE positive. A previous study conducted in 2016 showed that the prevalence of breast cancer screening was 18.7% in Indonesia and having a screening was associated with the level of knowledge of breast cancer’s risk factors, signs, and symptoms [44]. In this study, the estimated prevalence of VIA and CBE was 4.8% and 5.0%, respectively. To prevent female cancers more efficiently, the female cancer screening program is effective, but the screening prevalence should be increased through education and public awareness [37, 45].

There are some limitations to this study. First, this is an observational study and it might have selection bias, such as non-response bias, and information bias, such as reporting bias and recall bias. This study could not include some variables that have been reported as risk factors for cervical cancer or breast cancer, such as parity, gravidity, and BMI [7, 46, 47], because there were many missing data on these variables. Data were manually entered into the forms for the women cancer program database. Therefore, error reporting could easily occur. The results of this study may change when these variables are included in the analyses or the data are collected or entered correctly. Second, the results of further examinations and the final diagnoses in women who were positive for VIA and CBE were not available in this study. To evaluate the effectiveness of VIA and CBE in the screening program, this information is needed. A system for following positive cases in the screening program needs to be established. Third, the findings may not be representative of Indonesia’s entire population, because this study was conducted only in the Jakarta Province.

Conclusion

The positive rate was 0.9% for both VIA and CBE among the screening participants in Jakarta Province. Other than lifestyle factors and cancer family history, socio-demographic and reproductive factors that were associated with VIA positive and CBE positive were identified. To promote cancer prevention and the early detection of female cancer in Indonesia, the prevalence of screenings should be increased and education concerning risk factors should be provided to medical professionals.

Availability of data and materials

The data that support the findings of this study are available from the Jakarta Department of Health but restrictions apply to the availability of these data, which were used under license for the current study, and therefore are not publicly available. Data are however available from the authors upon reasonable request and with permission of the Jakarta Department of Health.

Abbreviations

BMI:

Body mass index

CBE:

Clinical breast examination

CI:

Confidence interval

CIN:

Cervical intraepithelial neoplasia

HPV:

Human papillomavirus

OR:

Odds ratio

Pap:

Papanicolaou

VIA:

Visual inspection with acetic acid

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Article  Google Scholar 

  2. Ngwa W, Olver I, Schmeler KM. The use of health-related technology to reduce the gap between developed and undeveloped regions around the Globe. Am Soc Clin Oncol Educ Book. 2020;40:1–10.

    Google Scholar 

  3. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.

    Article  CAS  Google Scholar 

  4. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.

    Article  Google Scholar 

  5. Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev. 2017;26(4):444–57.

    Article  Google Scholar 

  6. Rerucha CM, Caro RJ, Wheeler VL. Cervical Cancer screening. Am Fam Physician. 2018;97(7):441–8.

    Google Scholar 

  7. Tergas AI, Wright JD. Cancer prevention strategies for women. Obstet Gynecol. 2019;134(1):30–43.

    Article  Google Scholar 

  8. Gupta R, Gupta S, Mehrotra R, Sodhani P. Cervical Cancer screening in resource-constrained countries: current status and future directions. Asian Pac J Cancer Prev. 2017;18(6):1461–7.

    Google Scholar 

  9. Qiao L, Li B, Long M, Wang X, Wang A, Zhang G. Accuracy of visual inspection with acetic acid and with Lugol’s iodine for cervical cancer screening: Meta-analysis. J Obstet Gynaecol Res. 2015;41(9):1313–25.

    Article  CAS  Google Scholar 

  10. da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clin (Sao Paulo). 2017;72(4):244–53.

    Article  Google Scholar 

  11. Ngan TT, Nguyen NTQ, Van Minh H, Donnelly M, O’Neill C. Effectiveness of clinical breast examination as a ‘stand-alone’ screening modality: an overview of systematic reviews. BMC Cancer. 2020;20(1):1070.

    Article  Google Scholar 

  12. Albert US, Schulz KD. Clinical breast examination: what can be recommended for its use to detect breast cancer in countries with limited resources? Breast J. 2003;9(Suppl 2):90–3.

    Google Scholar 

  13. Eddy DM. Screening for breast cancer. Ann Intern Med. 1989;111(5):389–99.

    Article  CAS  Google Scholar 

  14. Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 1999;282(13):1270–80.

    Article  CAS  Google Scholar 

  15. University of Indonesia Strategic Studies Grant Recipient Team. Five Pillar Model in the implementation of Cervical Cancer Prevention Programs. Tim Penerima Hibah Kajian Strategis Universitas Indonesia. editor. Jakarta: UI Publishing; 2018.

    Google Scholar 

  16. Denny L, Quinn M, Sankaranarayanan R. Chapter 8: screening for cervical cancer in developing countries. Vaccine. 2006;24(Suppl 3):3/71–7.

    Google Scholar 

  17. Nessa A, Ara R, Fatema P, Nasrin B, Chowdhury A, Khan KH, et al. Influence of demographic and Reproductive factors on cervical pre-cancer and Cancer in Bangladesh. Asian Pac J Cancer Prev. 2020;21(7):1883–9.

    Article  Google Scholar 

  18. Ploysawang P, Rojanamatin J, Prapakorn S, Jamsri P, Pangmuang P, Seeda K, et al. National cervical Cancer screening in Thailand. Asian Pac J Cancer Prev. 2021;22(1):25–30.

    Article  CAS  Google Scholar 

  19. Adsul P, Manjunath N, Srinivas V, Arun A, Madhivanan P. Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: a systematic review. Cancer Epidemiol. 2017;49:161–74.

    Article  Google Scholar 

  20. Hu SY, Zhao XL, Zhao FH, Wei LH, Zhou Q, Niyazi M, et al. Implementation of visual inspection with acetic acid and Lugol’s iodine for cervical cancer screening in rural China. Int J Gynaecol Obstet. 2022;1–8. https://doi.org/10.1002/ijgo.14368.

  21. Newman LA. Breast cancer screening in low and middle-income countries. Best Pract Res Clin Obstet Gynaecol. 2022;83:15–23.

    Article  Google Scholar 

  22. WHO. Indonesia (Source: Globocan 2020). 2021.  Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf. Cited 2021 June 21.

  23. Nuranna L, Donny NB, Purwoto G, Winarto H, Utami TW, Anggraeni TD, et al. Prevalence, age distribution, and risk factors of Visual Inspection with acetic acid-positive from 2007 to 2011 in Jakarta. J Cancer Prev. 2017;22(2):103–7.

    Article  Google Scholar 

  24. Nuranna L, Aziz MF, Cornain S, Purwoto G, Purbadi S, Budiningsih S, et al. Cervical cancer prevention program in Jakarta, Indonesia: see and treat model in developing country. J Gynecol Oncol. 2012;23(3):147–52.

    Article  Google Scholar 

  25. Kardinah D, Anderson BO, Duggan C, Ali IA, Thomas DB. Short report: limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia. Int J Cancer. 2014;134(5):1250–5.

    Article  CAS  Google Scholar 

  26. Sirait LM, Anggreni LA, Pradibta CA, Widyastuti W, Prasetyo WE, Puspitasari HD, et al. Prevalence and factors associated with visual inspection of the cervix after acetic acid application positive result among female civil servants and wives of civil servants in Jakarta. Future Healthc J. 2019;6(Suppl 1):82.

    Article  Google Scholar 

  27. Wahidin M, Febrianti R, Susanty F, Hasanah SR. Twelve years implementation of cervical and breast Cancer screening program in Indonesia. Asian Pac J Cancer Prev. 2022;23(3):829–37.

    Article  Google Scholar 

  28. Veitch D, Goossens R, Owen H, Veitch J, Molenbroek J, Bochner M. Evaluation of conventional training in clinical breast examination (CBE). Work. 2019;62(4):647–56.

    Article  Google Scholar 

  29. Batubara JR, Soesanti F, van de Waal HD. Age at menarche in indonesian girls: a national survey. Acta Med Indones. 2010;42(2):78–81.

    Google Scholar 

  30. WHO. Guidelines on physical activity and sedentary Behaviour. Geneva: WHO; 2020.

    Google Scholar 

  31. Bray F, Soerjomataram I. The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): World Bank; 2015.

  32. Coughlin SS. Epidemiology of breast Cancer in women. Adv Exp Med Biol. 2019;1152:9–29.

    Article  CAS  Google Scholar 

  33. Tamimi RM, Spiegelman D, Smith-Warner SA, Wang M, Pazaris M, Willett WC, et al. Population attributable risk of modifiable and nonmodifiable breast Cancer risk factors in postmenopausal breast Cancer. Am J Epidemiol. 2016;184(12):884–93.

    Article  Google Scholar 

  34. McCormack VA, Boffetta P. Today’s lifestyles, tomorrow’s cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol. 2011;22(11):2349–57.

    Article  CAS  Google Scholar 

  35. Dalton M, Holzman E, Erwin E, Michelen S, Rositch AF, Kumar S, et al. Patient navigation services for cancer care in low-and middle-income countries: a scoping review. PLoS ONE. 2019;14(10):e0223537.

    Article  CAS  Google Scholar 

  36. Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer. 2011;117(15 Suppl):3539–42.

    Google Scholar 

  37. Dare AJ, Knapp GC, Romanoff A, Olasehinde O, Famurewa OC, Komolafe AO, et al. High-burden cancers in Middle-income countries: a review of Prevention and early detection strategies targeting At-risk populations. Cancer Prev Res (Phila). 2021;14(12):1061–74.

    Article  Google Scholar 

  38. Lertcharernrit J, Sananpanichkul P, Suknikhom W, Bhamarapravatana K, Suwannarurk K, Leaungsomnapa Y. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic acid for pregnant women at a thai Provincial Hospital. Asian Pac J Cancer Prev. 2016;17(8):4163–7.

    Google Scholar 

  39. Zhang Q, Xie W, Wang F, Li RH, Cui L, Wang H, et al. Epidemiological investigation and risk factors for cervical lesions: cervical Cancer screening among women in rural Areas of Henan Province China. Med Sci Monit. 2016;22:1858–65.

    Article  Google Scholar 

  40. Vidhubala E, Shewade HD, Niraimathi AK, Ramkumar S, Ramaswamy G, Nagalekshmi G, et al. Call for systematic Population-Based cervical Cancer screening: findings from Community-Based screening camps in Tamil Nadu, India. Asian Pac J Cancer Prev. 2019;20(12):3703–10.

    Article  Google Scholar 

  41. Dhakal R, Noula M, Roupa Z, Yamasaki EN. A scoping review on the Status of female breast Cancer in Asia with a special focus on Nepal. Breast Cancer (Dove Med Press). 2022;14:229–46.

    Google Scholar 

  42. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.

    Article  Google Scholar 

  43. Bekos C, Schwameis R, Heinze G, Garner M, Grimm C, Joura E, et al. Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis. Sci Rep. 2018;8(1):6383.

    Article  Google Scholar 

  44. Solikhah S, Lianawati L, Matahari R, Rejeki DSS. Determinants of breast Cancer screening practice among women in Indonesia: a Nationwide Study. Asian Pac J Cancer Prev. 2021;22(5):1435–41.

    Article  Google Scholar 

  45. Islam RM, Billah B, Hossain MN, Oldroyd J. Barriers to cervical Cancer and breast Cancer screening uptake in low-income and middle-income Countries: a systematic review. Asian Pac J Cancer Prev. 2017;18(7):1751–63.

    Google Scholar 

  46. Pfeiffer RM, Webb-Vargas Y, Wheeler W, Gail MH. Proportion of U.S. Trends in breast Cancer incidence attributable to long-term changes in risk factor distributions. Cancer Epidemiol Biomarkers Prev. 2018;27(10):1214–22.

    Article  Google Scholar 

  47. Karadag Arli S, Bakan AB, Aslan G. Distribution of cervical and breast cancer risk factors in women and their screening behaviours. Eur J Cancer Care (Engl). 2019;28(2):e12960.

    Article  Google Scholar 

Download references

Acknowledgements

We appreciate all staff of the section for non-communicable diseases of the Jakarta Department of Health and 44 Jakarta Public Health Centers for their technical support and assistance with the screening procedures and data collection process.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Healthcare Administration, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan

    Lady Margaretha Febriany Sirait, Nobuyuki Hamajima, Yunosuke Suzuki, Souphalak Inthaphatha, Kimihiro Nishino & Eiko Yamamoto

  2. Jakarta Department of Health, DKI Jakarta Provincial Government, Jalan Kesehatan Raya No. 10, Kecamatan Gambir, Kota Jakarta Pusat, DKI Jakarta, Indonesia

    Lady Margaretha Febriany Sirait, Endang Sri Wahyuningsih, Dwi Oktavia &  Widyastuti

Authors
  1. Lady Margaretha Febriany Sirait
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuyuki Hamajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yunosuke Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Endang Sri Wahyuningsih
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dwi Oktavia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Widyastuti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Souphalak Inthaphatha
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kimihiro Nishino
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Eiko Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LMFS and EY designed the study and developed the analysis plan. LMFS, ESW, and DO collected the data. LMFS and EY analyzed the data, and wrote the manuscript. NH supported the analysis. W, YS, NH, SI, KN, and YE revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Eiko Yamamoto.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Nagoya University Graduate School of Medicine (Nagoya, Japan) and the approval number was 2021 − 0130. Written informed consent was obtained from each woman who had VIA and/or CBE in the Jakarta Women Cancer Screening program. All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare that there are no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Additional file 1

Women cancer early detection procedure form.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sirait, L.M.F., Hamajima, N., Suzuki, Y. et al. Factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia: a cross-sectional study. BMC Cancer 22, 1309 (2022). https://doi.org/10.1186/s12885-022-10381-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-022-10381-1

Keywords

  • Breast cancer
  • Cancer screening
  • Cervical cancer
  • Indonesia
  • Population-based
  • Risk factors

BMC Cancer

ISSN: 1471-2407

Contact us